A review on the dosimetrical and radiobiological prediction of radiation-induced hypothyroidism in radiation therapy of head-and-neck cancer, breast cancer, and Hodgkin’s lymphoma survivors

Open access

Abstract

A review on the radiobiological modeling of radiation-induced hypothyroidism after radiation therapy of head-and-neck cancers, breast cancer, and Hodgkin’s lymphoma is presented. The current review is based on data relating to dose-volume constrains and normal tissue complication probability (NTCP) as a function of either radiobiological or (pre)treatment-clinical parameters. Also, these data were explored in order to provide more helpful criteria for radiobiological optimization of treatment plans involving thyroid gland as a critical normal organ.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Mirinezhad SK Somi MH Jangjoo AG et al. Survival rate and prognostic factors of esophageal cancer in East Azerbaijan province North-west of Iran. Asian Pac J Cancer Prev. 2012;13(7):3451-3454.

  • [2] Mirinezhad SK Somi MH Seyednezhad F et al: Influence of chemoradio therapeutic strategies and factors on the five yearssurvival of patients with esophageal cancer. Journal of Isfahan Medical School 2014;32(291):982-990.

  • [3] Mohammadzadeh M Faramarzi E Mahdavi R et al. Effect of conjugated linoleic acid supplementation on inflammatory factors and matrix metalloproteinase enzymes in rectal cancer patients undergoing chemoradiotherapy. Integr Cancer Ther. 2013;12(6):496-502.

  • [4] Mesbahi A Dadgar H Ghareh-Aghaji N Mohammadzadeh M. A Monte Carlo approach to lung dose calculation in small fields used in intensity modulated radiation therapy and stereotactic body radiation therapy. J Cancer Res Ther. 2014;10(4):896-902.

  • [5] Mesbahi A Dadgar H. Dose calculations accuracy of TiGRT treatment planning system for small IMRT beamlets in heterogeneous lung phantom. Int J Radiat Res. 2015;13(4):345-354.

  • [6] Mesbahi A Akcay D Tekcan IV Alikus ZA. The impact of residual geometric inaccuracies on normal organ doses in image guided-radiation therapy of prostate cancer using on-board kilovoltage Cone-Beam computed tomography. Iran J Med Phys. 2017;14(2):104-113.

  • [7] Mohammadzadeh M Mesbahi A. MC estimation of out-of-field organ doses from scattered photons photoneutrons and capture gamma rays in prostate radiation therapy. Nuclear Technology and Radiation Protection. 2010;25:78-84.

  • [8] Boyle P Levin B: World Cancer Report 2008. International Agency for Research on Cancer.

  • [9] Jemal A Siegel R Ward E et al. Cancer statistics 2007. CA Cancer J Clin. 2007;57:43-66.

  • [10] NCCN Clinical Practice Guidelines in Oncology. Breast cancer. ver.2. 2016. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf: 2017.

  • [11] Wang SA Rahemtullah A Faquin WC et al. Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol. 2005;18(12):1577-1584.

  • [12] Alterio D Jereczek-Fossa BA Franchi B et al. Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients. Int J Radiat Oncol Biol Phys. 2007;67(1):144-150.

  • [13] Bethge W Guggenberger D Bamberg M et al. Thyroid toxicity of treatment for Hodgkin’s disease. Ann Hematol. 2000;79(3):114-118.

  • [14] Reinertsen KV Cvancarova M Wist E et al. Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys. 2009;75(3):764-770.

  • [15] Hancock SL McDougall IR Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys. 1995;31(5):1165-1170.

  • [16] Jereczek-Fossa BA Alterio D Jassem J et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev. 2004;30(4):369-384.

  • [17] Bhandare N Kennedy L Malyapa RS et al. Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys. 2007;68(4):1131-1139.

  • [18] Kuten A Lubochitski R Fishman G et al. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol. 1996;61(4):281-283.

  • [19] Boomsma MJ Bijl HP Langendijk JA. Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review. Radiother Oncol. 2011;99(1):1-5.

  • [20] Mercado G Adelstein DJ Saxton JP et al. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 2001;92(11):2892-2897.

  • [21] Tell R Lundell G Nilsson B et al. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;60(2):395-400.

  • [22] Akyurek S Babaoglu I Kose K Gokce SC. Thyroid Dysfunction Following Supraclavicular Irradiation in the Management of Carcinoma of the Breast. In J Hemat Oncol. 2014;24(2):139-144.

  • [23] Kikawa Y Kosaka Y Hashimoto K et al. Prevalence of hypothyroidism among patients with breast cancer treated with radiation to the supraclavicular field: a single-centre survey. ESMO Open 2017;2:e000161.

  • [24] Smith GL Smith BD Giordano SH et al. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer. 2008;112(6):1371-1379.

  • [25] Fuks Z Glatstein E Marsa GW et al. Long-term effects on external radiation on the pituitary and thyroid glands. Cancer. 1976;37(2Suppl):1152-1161.

  • [26] Bakhshandeh M Hashemi B Mahdavi SR et al. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85(2):514-521.

  • [27] V.D’Avino Conson M Palma G et al. Normal Tissue Complication Probability Models for Radiation-Induced Hypothyroidism in Hodgkin Lymphoma Survivors. Int J Radiat Oncol Biol Phys. 2016;96(2):E638.

  • [28] Goldberg RC Chaikoff ILLindsay S Feller DD. Histopathological changes induced in the normal thyroid and other tissues of the rat by internal radiation with various doses of radioactive iodine. Endocrinology. 1950;46(1):72-90.

  • [29] Nishiyama K Tanaka E Tarui Y et al. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int J Radiat Oncol Biol Phys. 1996;34(2):439-444.

  • [30] Bakhshandeh M Hashemi B Mahdavi SR et al. Evaluation of thyroid disorders during head-and-neck radiotherapy by using functional analysis and ultrasonography. Int J Radiat Oncol Biol Phys. 2012;83(1):198-203.

  • [31] Carr RF LiVolsi VA. Morphologic changes in the thyroid after irradiation for Hodgkin’s and non-Hodgkin’s lymphoma. Cancer. 1989;64(4):825-829.

  • [32] Lo Galbo AM Kuik DJ Lips P et al. A prospective longitudinal study on endocrine dysfunction following treatment of laryngeal or hypopharyngeal carcinoma. Oral Oncol. 2013;49(9):950-955.

  • [33] Hancock SL Cox RS McDougall IR. Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med. 1991;325(9):599-605.

  • [34] Norris AA Amdur RJ Morris CG Mendenhall WM. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy. Am J Clin Oncol. 2006;29(5):442-445.

  • [35] Brix TH Kyvik KO Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85(2):536-539.

  • [36] Brix TH Hansen PS Kyvik KO Hegedus L. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med. 2000;160(5):661-666.

  • [37] Brix TH Hegedus L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol (Oxf). 2012;76(4):457-464.

  • [38] Laurberg P Cerqueira C Ovesen L et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab. 2010;24(1):13-27.

  • [39] Kumpulainen EJ Hirvikoski PP Virtaniemi JA et al. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol. 2000;57(1):97-101.

  • [40] Bonato C Severino RF Elnecave RH. Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radiotherapy. J Pediatr Endocrinol Metab. 2008;21(10):943-949.

  • [41] Garcia-Serra A Amdur RJ Morris CG et al. Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol. 2005;28(3):255-258.

  • [42] Grande C. Hypothyroidism following radiotherapy for head and neck cancer: multivariate analysis of risk factors. Radiother Oncol. 1992;25(1):31-36.

  • [43] Sklar C Whitton J Mertens A et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000;85(9):3227-3232.

  • [44] Akgun Z Atasoy BM Ozen Z et al. V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck. Radiat Oncol. 2014;9:104.

  • [45] Cella L Conson M Caterino M et al. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1802-1808.

  • [46] Chyan A Chen J Shugard E et al. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol. 2014;9:269.

  • [47] Fujiwara M Kamikonya N Odawara S et al. The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases. J Radiat Res. 2015;56(3):577-582.

  • [48] Sachdev S Refaat T Bacchus ID et al. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT). Am J Clin Oncol. 2017;40(4):413-417.

  • [49] Zhai RP Kong FF Du CR et al. Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study. Oral Oncol. 2017;68:44-49.

  • [50] Marks LB Yorke ED Jackson A et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76:S10-S19.

  • [51] Emami B Lyman J Brown A et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109-122.

  • [52] Boomsma MJ Bijl HP Christianen ME et al. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. Int J Radiat Oncol Biol Phys. 2012;84:e351-e356.

  • [53] Kim ES Yeo SG. Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: A dosimetrical analysis. Oncol Lett. 2014;7(6):1987-1991.

  • [54] Tsougos I Mavroidis P Rajala J et al. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy. Phys Med Biol. 2005;50(15):3535-3554.

  • [55] Burman C Kutcher GJ Emami B Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21(1):123-135.

  • [56] Emami B. Tolerance of Normal Tissue to Therapeutic Radiation. Rep Radiother Oncol. 2013;1(1):123-127.

  • [57] Cella L Liuzzi R Conson M et al. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiation Oncology. 2012;7:224.

  • [58] Ronjom MF Brink C Bentzen SM et al. Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction. Radiother Oncol. 2013;109(2):317-322.

  • [59] Ronjom MF Brink C Lorenzen EL et al. Variation of normal tissue complication probability (NTCP) estimates of radiation-induced hypothyroidism in relation to changes in delineation of the thyroid gland. Acta Oncol. 2015;54(8):1188-1194.

  • [60] Johansen S Reinertsen KV Knutstad K et al. Dose distribution in the thyroid gland following radiation therapy of breast cancer-a retrospective study. Radiat Oncol. 2011;6:68.

  • [61] Tunio MA Al AM Bayoumi Y et al. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study. J Cancer Res Ther. 2015;11(4):684-689.

  • [62] Sommat K Ong WS Hussain A et al. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2017;98(3):574-580.

  • [63] Kim MY Yu T Wu HG. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. Jpn J Clin Oncol. 2014;44(3):331-337.

  • [64] Jackson A Kutcher GJ Yorke ED. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys. 1993;20(3):613-625.

  • [65] Niemierko A Goitein M. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys. 1993;25(1):135-145.

  • [66] Yorke ED Kutcher GJ Jackson A Ling CC. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol. 1993;26(3):226-237.

  • [67] Lo Galbo AM de BR Kuik DJ et al. The prevalence of hypothyroidism after treatment for laryngeal and hypopharyngeal carcinomas: are autoantibodies of influence? Acta Otolaryngol. 2007;127(3):312-317.

  • [68] Vogelius IR Bentzen SM Maraldo MV et al. Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer. 2011;117(23):5250-5260.

  • [69] Diaz R Jaboin JJ Morales-Paliza M et al. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010;77(2):468-476.

  • [70] Wu YH Wang HM Chen HH et al. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 2010;76(4):1133-1139.

  • [71] Lin Z Wu VW Lin J et al. A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma. Thyroid. 2011;21(1):19-23.

  • [72] Srikantia N Rishi KS Janaki MG et al. How common is hypothyroidism after external radiotherapy to neck in head and neck cancer patients? Indian J Med Paediatr Oncol. 2011;32(3):143-148.

  • [73] Siala W Mnejja W Abid M et al. Thyroid toxicity after radiotherapy of nasopharyngeal carcinoma. Annales d’Endocrinologie. 2011;72(1):19-23.

  • [74] Lin Z Wang X Xie W et al. Evaluation of clinical hypothyroidism risk due to irradiation of thyroid and pituitary glands in radiotherapy of nasopharyngeal cancer patients. J Med Imaging Radiat Oncol. 2013;57(6):713-718.

  • [75] Lin Z Chen L Fang Y et al. Longitudinal study on the correlations of thyroid antibody and thyroid hormone levels after radiotherapy in patients with nasopha-ryngeal carcinoma with radiation-induced hypothyroidism. Head Neck. 2014;36(2):171-175.

  • [76] Murthy V Narang K Ghosh-Laskar S at al. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: Prospective data from 2 randomized con-trolled trials. Head Neck. 2014;36(11):1573-1580.

  • [77] Lauro C Macy ME Zeitler P et al. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation. J Pediatr Endocrinol Metab. 2014;27(3-4):299-303.

  • [78] Bernat L Hrusak D. Hypothyroidism after radiotherapy of head and neck cancer. J Craniomaxillofac Surg. 2014;42(4):356-361.

  • [79] Lee V Chan SY Choi CW et al. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma. Clin Oncol. 2016;28(8):e52-e60.

Search
Journal information
Impact Factor


CiteScore 2018: 0.38

ICV 2017 = 103.49

SCImago Journal Rank (SJR) 2018: 0.132
Source Normalized Impact per Paper (SNIP) 2018: 0.303

Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 211 211 5
PDF Downloads 139 139 7